Bausch Health Companies (BHC) Change in Acquisitions & Divestments (2009 - 2026)
Bausch Health Companies (BHC) posted Change in Acquisitions & Divestments of $4.0 million for Q2 2026, up 300.0% sequentially from $1.0 million in Q1 2026, and up 300.0% YoY from $1.0 million in Q2 2025.
Bausch Health Companies (BHC) Change in Acquisitions & Divestments (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Change in Acquisitions & Divestments for 18 years, with the latest figure at $4.0 million in Q2 2026.
- Quarterly Change in Acquisitions & Divestments rose 300.0% year-over-year to $4.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.0 million (down 33.33% YoY) and the FY2025 annual result came in at $8.0 million, down 42.86% from the prior year.
- Change in Acquisitions & Divestments improved to $4.0 million in Q2 2026 per BHC's latest filing, from $1.0 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $13.0 million in Q4 2023 and troughed at -$2.0 million in Q2 2023.
- A 5-year average of $4.2 million and a median of $4.0 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- The widest YoY moves for Change in Acquisitions & Divestments: up 550.0% in 2023, down 128.57% in 2023.
- Over 5 years, Change in Acquisitions & Divestments stood at $2.0 million in 2022, then surged by 550.0% to $13.0 million in 2023, then slumped by 76.92% to $3.0 million in 2024, then plunged by 33.33% to $2.0 million in 2025, then surged by 100.0% to $4.0 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $4.0 million, $1.0 million, and $2.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Bausch Health Companies | 2.56 Bn | 725.13 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.00 Mn |
| Jun 30, 2026 | 4.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Mar 31, 2024 | 6.00 Mn |